🇮🇳 Krazati in India

Krazati (ADAGRASIB) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Krazati in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in India

Frequently asked questions

Is Krazati approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Krazati in India?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.